Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Net loss from continuing operations

$

(7,083,941

)

$

(3,007,673

)

$

(15,956,537

)

$

(4,653,028

)

Less: Preferred stock dividends

(776,562

)

(776,562

)

(1,553,125

)

(1,553,125

)

Net loss from continuing operations attributable to LifeMD, Inc. common stockholders

(7,860,503

)

(3,784,235

)

(17,509,662

)

(6,206,153

)

Net income from discontinued operations

-

1,893,084

-

3,886,506

Less: Net income attributable to noncontrolling interests of discontinued operations

-

505,075

-

1,036,920

Net income from discontinued operations attributable to LifeMD, Inc. common stockholders

-

1,388,009

-

2,849,586

Net loss attributable to LifeMD, Inc. common stockholders

$

(7,860,503

)

$

(2,396,226

)

$

(17,509,662

)

$

(3,356,567

)